Correlation between of hepatitis A virus infection and vitamin B12 level in Iraqi patients
Keywords:
HAV, hepatitis, vitamin b12, HAV IgMAbstract
Hepatitis A is a public health problem all over the world, especially in developing countries, because the virus is so common in the environment. Anti-HAV IgM antibodies were detected in the serum of 100 of the 120 persons (patients group) collected from the Al-Zahra hospital in Al-rusafa/Baghdad between November 2021 and March 2022. Twenty individuals with negative blood levels of anti-HAV IgM antibodies were deemed a control group. Anti-HAV IgM antibodies were significantly higher (P
<0.001) in hepatitis A patients than controls using a solid phase, two-step incubation, antibody capture ELISA kit, indicating acute infection. The majority of HAV patients (91% of all patients) were found during the first decade (1-10 years), whereas 9% were found within the second decade (10-20 years). HAV infection is spread evenly across genders in this research. As a result, females and males had no statistically considerable differences, with a ratio of (1 female: 0.786 male) and a proportion of 56% females vs 44% males. The study showed a considerable decrease in vitamin B12 in male patients with HAV (426.09 ± 35.61 pg/mL) comparing with healthy control (566.45 ± 28.06 pg/mL) (P= 0.001). While in females, the findings displayed a considerable decrease in the patient’s group (595.01 ± 47.47 pg/mL) compared with the control group(721.04 ± 58.28 pg/mL)>
References
Al Faleh, F., Al Shehri, S., Al Ansari, S., Al Jeffri, M., Al Mazrou, Y., Shaffi, A. and Abdo, A. A. (2008). Changing patterns of hepatitis A prevalence within the Saudi population over the last 18 years. World J Gastroenterol.14:7371-7375.
Alkhalidi, J., Alenezi, B., Al-Mufti, S., Hussain, E., Askar, H., Kemmer, N.,and Neff, G.W. (2009). Seroepidemiology of hepatitis A virus in Kuwait. World J Gastroenterol. 15:102-5.
Almuneef, M. A., Memish, Z. A., Balkhy, H. H., Qahtani, M., Alotaibi, B., Hajeer, A., Qasim,L. and Al Knawe, B.(2006). Epidemiologic shift in the prevalence of hepatitis A virus in Saudi Arabia: A case for routine Hepatitis A vaccination. Vaccine. 24:5599-5603.
Antaki, N. and Kebbewar, M. K. (2000). Hepatitis A seroprevalence rate in Syria. Trop Doct. 30:99-101.
Aziz, S., Muzaffar, R., Hafiz, S., Abbas, Z., Zafar, M. N., Naqvi, S. A. and Rizvi, S. A. (2007). Helicobacter pylori, hepatitis viruses A, C, E, antibodies and HBsAg-prevalence and associated risk factors in pediatric communities of Karachi. J Coll Physicians Surg Pak. 17:195-198.
Barrientos-Gutierrez, T. , Brizuela-Alcantara, D. and Chavez-Tapia, G. (2011). Hepatitis A Virus infection in high risk subjects. Annais of Hepatology. 10:578-579..
Battikhi, M. N.and Battikhi, E. G. (2004). The seroepidemiology of Hepatitis A virus in Amman, Jordan. New Microbiol. 27:215-220.
Berge, J. J., Drennan, D. P., Jacobs, R. J., Jakins, A., Meyerhoff, A. S., Stubblefield, W. and Weinberg, M.(2000). The cost of hepatitis A infections in American adolescents and adults in 1997. Hepatology. 31:469-473.
Bizri, A. R., Nuwayhid, I. A., Hamadeh, G. N., Steitieh, S. W., Choukair, A. M. and Musharrafieh, U. M. (2006). Association between hepatitis A virus and Helicobacter pylori in a developing country: The saga continues. J Gastroenterol Hepatol. 21:1615-1621.
Cetinkaya, B. Tezer, H. Parlakay, A. O. and Saylı, T. R. (2014). Evaluation of pediatric patients with hepatitis A. J Infect Dev Ctries. 8:326-330.
Chironna, M., Germinario, C., Lopalco, P. L., Carrozzini, F., Barbuti, S. and Quarto, M. (2003). Prevalence rates of viral hepatitis infections in refugee Kurds from Iraq and Turkey. Infection. 31:70-74.
Kaya,D., Guler, E., Ekerbicer, H. C., Dilber, C., Karabiber, H., Guler, S., Davutoglu, M. and Ciragil, P. (2007). Hepatitis A seroprevalence and its relationship with environmental factors in children of different age groups in Kahramanmaras, Eastern Mediterranean region of Turkey. J Viral Hepat. 14:830-834.
Lemon, S. M. (1997). Type A viral hepatitis: epidemiology, diagnosis, and prevention. Clinical ChemistryAugust .43: 1494-1499.
Mehr, A. J., Ardakani, M. J., Hedayati, M., Shahraz, S., Mehr, E. J. and Zali, M. R. (2004). Age-specific seroprevalence of hepatitis A infection among children visited in pediatric hospitals of Tehran, Iran. Eur J Epidemiol. 19: 275 – 278.
MohdHanafiah, K., Jacobsen, K.H. and Wiersma, S.T.(2011). Challenges to mapping the health risk of hepatitis A virus infection. Int J Health Geogr. 10:57.
Salama, I. I., Samy, S. M., Shaaban, F. A., Hassanin, A. I. and Abou Ismail, L. A. (2007). Seroprevalence of hepatitis A among children of different socioeconomic status in Cairo. East Mediterr Health J. 13:1256-1264.
Sharar, Z. A., Rajah, J. and Parsons, H. (2008). Childhood seroprevalence of hepatitis A in the United Arab Emirates. Trop Doct. 38:65-66.
Turky, A. M., Akram, W., Al-Naaimi, A. S., Omer, A. R. and Al- Rawi, J. R.(2011). Analysis of acute viral hepatitis (A and E) in Iraq. Global Journal of Health Science. 3:70- 76.
Wang, C. H., Tschen, S. Y., Heinricy, U., Weber, M. and Flehmig, B. (1996). Immune response to hepatitis A virus capsid proteins after infection. J. Clin. Microbiol. 34:707-713.
Wheeler, C., Vogt, T. M., Armstrong, G.L., Vaughan, G., Weltman, A., Nainan, O. V., Dato, V., Xia, G., Waller, K., Amon, J., Lee, T. M., Highbaugh-Battle, A., Hembree, C., Evenson, S., Ruta, M. A., Williams, I. T., Fiore, A. E. and Bell, B. P. (2005). An Outbreak of Hepatitis A associated with green onions. N Engl J Med. 353:890-897.
World Health Organization. (2014) . Hepatitis A Fact sheet N°328. WHO.
Wu, J., Zou, S. and Giulivi, A. (2001). Current hepatitis A status in Canada. Can J Infect Dis. 12:341-344.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
User Rights
Under the Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC), the author (s) and users are free to share (copy, distribute and transmit the contribution).
Rights of Authors
Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.